Slart RHJA - Search Results

1

Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with ¹³N-NH₃ positron emission tomography and echocardiography.

Assa S, Kuipers J, Ettema E, Gaillard CAJM, Krijnen WP, Hummel YM, Voors AA, van Melle JP, Westerhuis R, Willemsen A, Slart RHJA, Franssen CFM. Assa S, et al. Among authors: slart rhja. Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F445-F452. doi: 10.1152/ajprenal.00368.2017. Epub 2017 Nov 8. Am J Physiol Renal Physiol. 2018. PMID: 29117996 Free article. Clinical Trial.

2

Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.

De Boer J, Slart RH, Blanksma PK, Willemsen AT, Jager PL, Paans AM, Vaalburg W, Piers DA. De Boer J, et al. Nucl Med Commun. 2003 Mar;24(3):251-7. doi: 10.1097/00006231-200303000-00004. Nucl Med Commun. 2003. PMID: 12612465

3

Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease.

Slart RH, Bax JJ, de Jong RM, de Boer J, Lamb HJ, Mook PH, Willemsen AT, Vaalburg W, van Veldhuisen DJ, Jager PL. Slart RH, et al. J Nucl Med. 2004 Feb;45(2):176-82. J Nucl Med. 2004. PMID: 14960633 Free article. Clinical Trial.

4

PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease.

Tio RA, Tan ES, Jessurun GA, Veeger N, Jager PL, Slart RH, de Jong RM, Pruim J, Hospers GA, Willemsen AT, de Jongste MJ, van Boven AJ, van Veldhuisen DJ, Zijlstra F. Tio RA, et al. J Nucl Med. 2004 Sep;45(9):1437-43. J Nucl Med. 2004. PMID: 15347709 Free article. Clinical Trial.

5

Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.

de Jong RM, Willemsen AT, Slart RH, Blanksma PK, van Waarde A, Cornel JH, Vaalburg W, van Veldhuisen DJ, Elsinga PH. de Jong RM, et al. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):443-7. doi: 10.1007/s00259-004-1701-z. Epub 2004 Dec 11. Eur J Nucl Med Mol Imaging. 2005. PMID: 15592928 Clinical Trial.

6

Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.

Slart RH, Bax JJ, de Boer J, Willemsen AT, Mook PH, Oudkerk M, van der Wall EE, van Veldhuisen DJ, Jager PL. Slart RH, et al. Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):972-9. doi: 10.1007/s00259-005-1785-0. Epub 2005 Apr 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15824927 Clinical Trial.

7

Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.

Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Irwan R, Sluiter WJ, Dierckx RA, de Boer J, Jager PL. Slart RH, et al. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):716-23. doi: 10.1007/s00259-005-0016-z. Epub 2006 Mar 8. Eur J Nucl Med Mol Imaging. 2006. PMID: 16523309 Clinical Trial.

8

Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.

Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, de Boer J, Jager PL. Slart RH, et al. J Nucl Cardiol. 2006 Mar-Apr;13(2):210-9. doi: 10.1007/BF02971245. J Nucl Cardiol. 2006. PMID: 16580957 Clinical Trial.

9

Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: a [13N]ammonia positron emission tomography study.

de Vries J, DeJongste MJ, Jessurun GA, Jager PL, Staal MJ, Slart RH. de Vries J, et al. Nucl Med Commun. 2006 Oct;27(10):791-4. doi: 10.1097/01.mnm.0000237984.46844.42. Nucl Med Commun. 2006. PMID: 16969261

10

Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III).

Belonje AM, Voors AA, van Gilst WH, Anker SD, Slart RH, Tio RA, Zijlstra F, van Veldhuisen DJ; HEBE III investigators. Belonje AM, et al. Am Heart J. 2008 May;155(5):817-22. doi: 10.1016/j.ahj.2007.12.036. Am Heart J. 2008. PMID: 18440327 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters